No ways we should even consider any offers at this low market value. Valuation will progressively increase to reflect the pathway to commercialisation as we go. From now on, we should be able to attract new investors to fund the trials at higher share price.
Not advice, DYOR!
- Forums
- ASX - By Stock
- AVR milestones
AVR
anteris technologies global corp.
Add to My Watchlist
0.00%
!
$6.12

No ways we should even consider any offers at this low market...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.12 |
Change
0.000(0.00%) |
Mkt cap ! $94.85M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2160 | $6.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.08 | 500 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2160 | 6.010 |
2 | 1624 | 6.000 |
1 | 310 | 5.860 |
2 | 195 | 5.850 |
1 | 857 | 5.830 |
Price($) | Vol. | No. |
---|---|---|
6.080 | 500 | 2 |
6.180 | 2109 | 3 |
6.190 | 1000 | 1 |
6.200 | 1000 | 1 |
6.400 | 130 | 1 |
Last trade - 10.00am 26/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
Day chart unavailable
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online